Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GEMCITABINE Cause Small intestinal obstruction? 78 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Small intestinal obstruction have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.3% of all adverse event reports for GEMCITABINE.

78
Reports of Small intestinal obstruction with GEMCITABINE
0.3%
of all GEMCITABINE reports
12
Deaths
62
Hospitalizations

How Dangerous Is Small intestinal obstruction From GEMCITABINE?

Of the 78 reports, 12 (15.4%) resulted in death, 62 (79.5%) required hospitalization, and 9 (11.5%) were considered life-threatening.

Is Small intestinal obstruction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 78 reports have been filed with the FAERS database.

What Other Side Effects Does GEMCITABINE Cause?

Off label use (3,319) Disease progression (3,123) Thrombocytopenia (2,320) Drug ineffective (2,003) Malignant neoplasm progression (1,962) Neutropenia (1,892) Anaemia (1,745) Pyrexia (1,511) Nausea (1,336) Myelosuppression (1,197)

What Other Drugs Cause Small intestinal obstruction?

ADALIMUMAB (1,665) INFLIXIMAB (351) VEDOLIZUMAB (341) BEVACIZUMAB (268) RISANKIZUMAB-RZAA (241) DOXORUBICIN (237) CLOZAPINE (211) PREDNISONE (190) CARBOPLATIN (178) FLUOROURACIL (178)

Which GEMCITABINE Alternatives Have Lower Small intestinal obstruction Risk?

GEMCITABINE vs GEMCITABINE\GEMCITABINE GEMCITABINE vs GEMFIBROZIL GEMCITABINE vs GEMTUZUMAB OZOGAMICIN GEMCITABINE vs GEMZAR GEMCITABINE vs GENTAMICIN

Related Pages

GEMCITABINE Full Profile All Small intestinal obstruction Reports All Drugs Causing Small intestinal obstruction GEMCITABINE Demographics